A novel nomogram to identify the III-N2 non-small cell lung cancer patients who may benefit from adjuvant radiotherapy

Author:

Yi Xinglin1,Deng Caixia1,He Yi1,Zhou Xiangdong1,Luo Hu1

Affiliation:

1. Southwest Hospital

Abstract

Abstract Purpose We aimed to develop a novel risk stratification system based on a prognostic nomogram to identify patients with pIII-N2 non-small cell lung cancer (NSCLC) who may benefit from postoperative radiotherapy (PORT) after complete resection. Methods We retrospectively enrolled 3,520 eligible NSCLC patients with pIII-N2 stage disease from the Surveillance, Epidemiology, and End Results database. Stabilized inverse probability of treatment weighting (sIPTW) was used to equilibrate the characteristic baseline to reduce bias. We established a risk stratification tool using a nomogram that incorporated independent factors identified using least absolute shrinkage and selection operator (LASSO) Cox regression. Kaplan–Meier and subgroup survival analyses were conducted to estimate the benefit of PORT in every risk stratification. Results Kaplan–Meier survival analysis observed that high-risk patients owned a significant improvement in overall survival (OS) after PORT (p = 0.002), while those in low- or intermediate-risk cohorts did not show such improvement. Subgroup survival analysis suggested that patients with a high lymph node ratio ≥ 0.56 (hazard ratio [HR] = 0.803; 95% confidence interval [CI]:0.661–0.975, p = 0.027), without postoperative chemotherapy (HR = 0.782; 95% CI: 0.619–0.989; p = 0.040), and those in the high-risk group (HR = 0.577; 95% CI: 0.410–0.812; p = 0.001) achieved a significant OS advantage from PORT. Conclusion This novel risk stratification system based on nomogram provides a preliminary identification of potential pIII-N2 NSCLC patients who are more likely to benefit from PORT.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3